Trials / NCT02617966
Rod and Cone Mediated Function in Retinal Disease
Recruiting now Observational Natural history / observational
- Sponsor
- National Eye Institute (NEI)
- Treatment
- Not listed
- Gene
- Not stated
- Conditions
- Retinal Degeneration, Retinitis Pigmentosa, Stargardt's Disease
- Ages
- 5 Years to 100 Years
- Enrollment
- 500 participants
- Started
- 2016-03-24
- Main results expected
- 2029-12-30
- Results posted
- Not yet
- Record last updated
- 2026-11-09
What the study is testing
Background:
Retinal diseases cause the loss of rod and cone photoreceptors. Symptoms include vision loss and night blindness. Researchers want to learn about rod and cone function in healthy people and people with retinal disease. They want to know if how well a person sees in the dark can test the severity of retinal disease.
Objectives:
To find out if how well a person sees in the dark can test the severity of retinal disease. To find out if this can help detect retinal disease and track its changes.
Eligibility:
People ages 5 and older with:
Retinal disease OR
20/20 vision or better with or without correction in at least one eye
Design:
Participants will be screened with medical and eye history and eye exam. Those with retinal disease will also have:
Eye imaging: Drops dilate the eye and pictures are taken of it.
Visual field testing: Participants look into a bowl and press a button when they see light.
Electroretinogram (ERG): An electrode is taped to the forehead. Participants sit in the
dark with their eyes patched for 30 minutes. Then they get numbing drops and contact
lenses. Participants watch lights while retina signals are recorded.
Visit 1 will be 3-8 hours. Participants will have up to 6 more visits over 6-12 months. Visits include:
Eye exam and imaging
Time course of dark adaptation: Participants view a background light for 5 minutes then
push a button when they see colored light.
Dark adapted sensitivity: Participants sit in the dark for 45 minutes. They push a button when
they see colored light.
For participants with retinal disease, ERG and visual field testing
...
Where it runs
United States (1)
- National Institutes of Health Clinical Center, Bethesda, Maryland (recruiting now)